These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


355 related items for PubMed ID: 18093232

  • 21. Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer.
    Gallego R, Codony-Servat J, García-Albéniz X, Carcereny E, Longarón R, Oliveras A, Tosca M, Augé JM, Gascón P, Maurel J.
    Endocr Relat Cancer; 2009 Mar; 16(1):311-7. PubMed ID: 19109398
    [Abstract] [Full Text] [Related]

  • 22. [Analysis of serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in benign prostatic hyperplasia].
    Yu JP, Wu XM, Chen JG, Liu WM, Yang QX.
    Zhonghua Nan Ke Xue; 2003 Aug; 9(5):341-3. PubMed ID: 14513639
    [Abstract] [Full Text] [Related]

  • 23. IGF-1, IGFBP-3 and ALS in adult patients with chronic kidney disease.
    Lepenies J, Wu Z, Stewart PM, Strasburger CJ, Quinkler M.
    Growth Horm IGF Res; 2010 Apr; 20(2):93-100. PubMed ID: 19932629
    [Abstract] [Full Text] [Related]

  • 24. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
    Mattera D, Capuano G, Colao A, Pivonello R, Manguso F, Puzziello A, D'Agostino L.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
    [Abstract] [Full Text] [Related]

  • 25. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY, Amin GM, Khalil GM, Ragab WS, Abaza MM.
    Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
    [Abstract] [Full Text] [Related]

  • 26. Leptin, VEGF, IGF-1, and IGFBP-3 concentrations in serum and follicular fluid of women undergoing in vitro fertilization.
    Dorn C, Reinsberg J, Kupka M, van der Ven H, Schild RL.
    Arch Gynecol Obstet; 2003 Aug; 268(3):187-93. PubMed ID: 12942249
    [Abstract] [Full Text] [Related]

  • 27. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A, Svensson D, Schuett B, Osterziel KJ, Ranke MB.
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [Abstract] [Full Text] [Related]

  • 28. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
    Berrigan D, Potischman N, Dodd KW, Nicar M, McQuillan G, Lavigne JA, Barrett JC, Ballard-Barbash R.
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
    [Abstract] [Full Text] [Related]

  • 29. Serum levels of IGF-I and IGFBP-III and their relation with carcinoembryonic antigen and carbohydrate antigen 19-9 in cases of esophageal cancer.
    Yilmaz O, Eroglu A, Dag E, Karaoglanoglu N, Yilmaz A.
    Int J Clin Pract; 2006 Dec; 60(12):1604-8. PubMed ID: 16704680
    [Abstract] [Full Text] [Related]

  • 30. Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma.
    Alexandrakis MG, Sfiridaki A, Miyakis S, Pappa C, Kandidaki E, Alegakis A, Margioris AN.
    Clin Chim Acta; 2007 Apr; 379(1-2):31-5. PubMed ID: 17234170
    [Abstract] [Full Text] [Related]

  • 31. Effect of glucocorticoid treatment on insulin like growth factor-I and its binding proteins in children with nephrotic syndrome.
    Dong F, Zhou X, Pang N, Wei M.
    Chin Med J (Engl); 2002 Sep; 115(9):1383-5. PubMed ID: 12411118
    [Abstract] [Full Text] [Related]

  • 32. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
    Hamaguchi Y, Fujimoto M, Matsushita T, Hasegawa M, Takehara K, Sato S.
    J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
    [Abstract] [Full Text] [Related]

  • 33. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
    Serrano ML, Romero A, Cendales R, Sánchez-Gómez M, Bravo MM.
    Biomedica; 2006 Jun; 26(2):258-68. PubMed ID: 16925098
    [Abstract] [Full Text] [Related]

  • 34. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
    Harris TG, Strickler HD, Yu H, Pollak MN, Monrad ES, Travin MI, Xue X, Rohan TE, Kaplan RC.
    Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
    [Abstract] [Full Text] [Related]

  • 35. Interactions between insulin, body fat, and insulin-like growth factor axis proteins.
    Ahmed RL, Thomas W, Schmitz KH.
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):593-7. PubMed ID: 17372257
    [Abstract] [Full Text] [Related]

  • 36. Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis.
    Jarkovská Z, Hodková M, Sazamová M, Rosická M, Dusilová-Sulková S, Marek J, Justová V, Lacinová Z, Haluzík M, Haas T, Krsek M.
    Growth Horm IGF Res; 2005 Dec; 15(6):369-76. PubMed ID: 16198134
    [Abstract] [Full Text] [Related]

  • 37. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
    Mathur RS, Mathur SP.
    Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460
    [Abstract] [Full Text] [Related]

  • 38. [Serum level of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in acute coronary syndromes and relationship with prognosis].
    Sekuri C, Arslan O, Utük O, Bayturan O, Onur E, Tezcan UK, Tavli T.
    Anadolu Kardiyol Derg; 2004 Sep; 4(3):209-12. PubMed ID: 15355821
    [Abstract] [Full Text] [Related]

  • 39. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome.
    Schoyer KD, Liu HC, Witkin S, Rosenwaks Z, Spandorfer SD.
    Fertil Steril; 2007 Jul; 88(1):139-44. PubMed ID: 17320874
    [Abstract] [Full Text] [Related]

  • 40. Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow.
    Abd El Aal DE, Mohamed SA, Amine AF, Meki AR.
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb 01; 118(2):219-24. PubMed ID: 15653207
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.